Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/29609
Title: | Natural language processing diagnosed behavioral disturbance vs confusion assessment method for the intensive care unit: prevalence, patient characteristics, overlap, and association with treatment and outcome. | Austin Authors: | Young, Marcus ;Holmes, Natasha E ;Kishore, Kartik ;Marhoon, Nada ;Amjad, Sobia;Serpa Neto, Ary ;Bellomo, Rinaldo | Affiliation: | Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.. Data Analytics Research and Evaluation (DARE) Centre Department of Critical Care, School of Medicine, The University of Melbourne, Parkville, Melbourne, VIC, Australia.. School of Computing and Information Systems, The University of Melbourne, Parkville, Melbourne, VIC, Australia.. Intensive Care |
Issue Date: | 2022 | Date: | 2022-03-23 | Publication information: | Intensive care medicine 2022; 48(5): 559-569 | Abstract: | To compare the prevalence, characteristics, drug treatment for delirium, and outcomes of patients with Natural Language Processing (NLP) diagnosed behavioral disturbance (NLP-Dx-BD) vs Confusion Assessment Method for intensive care unit (CAM-ICU) positivity. In three combined medical-surgical ICUs, we obtained data on demographics, treatment with antipsychotic medications, and outcomes. We applied NLP to caregiver progress notes to diagnose behavioral disturbance and analyzed simultaneous CAM-ICU. We assessed 2313 patients with a median lowest Richmond Agitation-Sedation Scale (RASS) score of - 2 (- 4.0 to - 1.0) and median highest RASS score of 1 (0 to 1). Overall, 1246 (53.9%) patients were NLP-Dx-BD positive (NLP-Dx-BDpos) and 578 (25%) were CAM-ICU positive (CAM-ICUpos). Among NLP-Dx-BDpos patients, 539 (43.3%) were also CAM-ICUpos. In contrast, among CAM-ICUpos patients, 539 (93.3%) were also NLP-Dx-BDpos. The use of antipsychotic medications was highest in patients in the CAM-ICUpos and NLP-Dx-BDpos group (24.3%) followed by the CAM-ICUneg and NLP-Dx-BDpos group (10.5%). In NLP-Dx-BDneg patients, antipsychotic medication use was lower at 5.1% for CAM-ICUpos and NLP-Dx-BDneg patients and 2.3% for CAM-ICUneg and NLP-Dx-BDneg patients (overall P < 0.001). Regardless of CAM-ICU status, after adjustment and on time-dependent Cox modelling, NLP-Dx-BD was associated with greater antipsychotic medication use. Finally, regardless of CAM-ICU status, NLP-Dx-BDpos patients had longer duration of ICU and hospital stay and greater hospital mortality (all P < 0.001). More patients were NLP-Dx-BD positive than CAM-ICU positive. NLP-Dx-BD and CAM-ICU assessment describe partly overlapping populations. However, NLP-Dx-BD identifies more patients likely to receive antipsychotic medications. In the absence of NLP-Dx-BD, treatment with antipsychotic medications is rare. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/29609 | DOI: | 10.1007/s00134-022-06650-z | ORCID: | http://orcid.org/0000-0002-1650-8939 0000-0002-6195-660X 0000-0001-8501-4054 0000-0003-1520-9387 |
Journal: | Intensive care medicine | PubMed URL: | 35322288 | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/35322288/ | Type: | Journal Article | Subjects: | Critical illness Delirium Intensive care Olanzapine Quetiapine |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.